Paroxysmal vs Persistent AF: Why the Difference Matters for Your Treatment

The question patients ask — and why the answer changes everything

One of the most common questions I am asked in clinic — sometimes accompanied by a slightly bewildered expression — is: ‘My cardiologist has said I have paroxysmal AF, but my friend has persistent AF. Are we talking about the same condition?’ The short answer is: yes and no. Both are atrial fibrillation. But the distinction between these two forms of the condition has profound implications for treatment choices, success rates, and long-term prognosis.

Understanding where you sit on the AF spectrum is not just academic — it is one of the most important pieces of information guiding the conversation between you and your cardiologist.

The Classification System

The 2024 European Society of Cardiology guidelines classify AF by the pattern of episodes:

• Paroxysmal AF: self-terminating episodes lasting less than seven days — most typically a few minutes to a few hours. The heart returns to normal rhythm on its own.
• Persistent AF: episodes lasting more than seven days, which require cardioversion — either electrical or pharmacological — to restore normal rhythm.
• Long-standing persistent AF: continuous AF for more than twelve months.
• Permanent AF: a designation used when both patient and physician have agreed not to pursue rhythm control, and the focus shifts to rate control and stroke prevention.

It is worth noting that permanent AF is a therapeutic decision, not an irreversible biological state. I have had patients reclassified from permanent to long-standing persistent when their circumstances or preferences changed — and who then went on to achieve excellent results from ablation.

Why Does It Matter for Ablation?

From an ablation standpoint, paroxysmal AF is significantly more amenable to catheter ablation than persistent or long-standing persistent AF, and understanding why helps patients set realistic expectations.

In paroxysmal AF, the arrhythmia is driven predominantly by triggers from the pulmonary veins. Pulmonary vein isolation — disconnecting those veins electrically from the atrial muscle — is therefore highly effective. Single-procedure success rates at 12 months in appropriately selected patients with paroxysmal AF are typically 70–80%.

In persistent AF, the arrhythmia has had longer to remodel the atria. A process called atrial fibrosis — scarring of the atrial wall — begins to develop, and the AF substrate extends beyond the pulmonary veins. This additional substrate may require more extensive ablation to address, and success rates are somewhat lower with a single procedure, though they continue to improve with techniques such as pulsed field ablation and high-resolution substrate mapping.

Does AF Progress Over Time?

Yes, often it does — and this is one of the most important things I discuss with patients in the early stages of their diagnosis. AF is a progressive condition. Without rhythm control, paroxysmal AF frequently progresses to persistent AF over months to years, as the atria undergo a process called atrial remodelling: the chambers enlarge, electrical properties change, and the substrate for sustained AF develops.

This progression is not inevitable, and the evidence increasingly supports early intervention to prevent it. The landmark EAST-AFNET 4 trial demonstrated that in patients with AF diagnosed within the previous 12 months, early rhythm control — whether by medication or ablation — significantly reduced the composite of cardiovascular death, stroke, hospitalisation for heart failure, and acute coronary syndrome, compared with a rate-control-first approach. This was true even when symptoms were mild. The message from this trial, and from the updated 2024 ESC guidelines, is clear: we should not delay rhythm control.

What This Means in Practice

If you have been diagnosed with paroxysmal AF, you are at a point where intervention is most likely to be effective. The window of opportunity for ablation to achieve the best results is open. If persistent AF has been present for some time, that window is not closed — but the procedure may be more complex and the expectations appropriately adjusted.

At OneWelbeck Heart Health, I assess each patient individually. There is no one-size-fits-all approach. I look at the pattern of your AF, your left atrial size on echocardiogram, the presence of reversible risk factors such as obesity, sleep apnoea and hypertension, and your own preferences and circumstances. Together, we decide on the right strategy for you.

To discuss your AF type and treatment options, book a consultation — drboonlim.co.uk or call 0208 187 9888